The views of Hillary Clinton and Donald Trump on Alzheimer’s research are important in and of themselves but also, perhaps, as a sign of their positions on medical research generally.
As the 2016 presidential election draws nearer, and because I write on life sciences and medical research for Bloomberg BNA, I tried to focus on a topic that might provide insights into both candidates’ approaches in this important public health arena.
Both candidates have made commitments to increase funding for Alzheimer’s research.
In addition to this unanimity, the topic is important because there is no cure for Alzheimer’s and every drug approved to treat it between 1998 and 2011 has been unsuccessful in preventing, curing or consistently reducing the disease’s symptoms.
Companies like Eli Lilly and Co., Biogen Inc., AbbVie, Merck, Roche Holding Ltd., Johnson & Johnson and others are actively involved in finding a treatment. But it has been an uphill battle, with some approaches targeting amyloid, a protein that clumps in the brain of Alzheimer's patients, and others targeting tau, an aberrant protein that spreads through the brain as Alzheimer’s progresses.
Clinton’s commitment was in the form of a $20 billion plan to find a cure for Alzheimer’s by 2025. Trump’s was in a statement, but I knew that he, like me, had lost a loved one to the disease. In his case it was his father.
You can find the full article here.
Stay on top of new developments in health law and regulation with a free trial to the Health Law Resource Center.
Learn more about Bloomberg Law and sign up for a free trial.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to email@example.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to firstname.lastname@example.org.
Put me on standing order
Notify me when new releases are available (no standing order will be created)